Westbourne Investment Advisors, Inc. Axsome Therapeutics, Inc. Transaction History

Westbourne Investment Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Jan 18, 2019	SELL	$2.0 - $4.15 $2,000 - $4,150	-1,000 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$2.3 - $3.55 $2,300 - $3,550	1,000 New	1,000 $3,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.77B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.